🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 8 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/10/2024 | 106,83 | 109,41 | 106,55 | 106,78 | +0,37% | 2,68% | 120.600 |
| 18/10/2024 | 106,08 | 106,57 | 104,25 | 106,39 | +0,47% | 2,19% | 53.600 |
| 17/10/2024 | 107,50 | 108,19 | 105,17 | 105,89 | -1,19% | 2,81% | 73.000 |
| 16/10/2024 | 105,26 | 107,76 | 104,35 | 107,16 | +2,65% | 3,24% | 109.900 |
| 15/10/2024 | 102,99 | 105,67 | 102,89 | 104,39 | +0,90% | 2,70% | 68.000 |
| 14/10/2024 | 103,06 | 103,59 | 101,99 | 103,46 | +0,51% | 1,55% | 61.000 |
| 11/10/2024 | 100,02 | 103,03 | 100,02 | 102,94 | +2,61% | 3,01% | 89.000 |
| 10/10/2024 | 102,05 | 102,42 | 98,90 | 100,32 | -2,83% | 3,45% | 78.600 |
| 09/10/2024 | 102,07 | 104,48 | 101,77 | 103,24 | +0,26% | 2,66% | 72.100 |
| 08/10/2024 | 102,95 | 105,50 | 102,28 | 102,97 | +0,34% | 3,13% | 57.500 |
| 07/10/2024 | 104,78 | 104,78 | 102,16 | 102,62 | -2,06% | 2,50% | 74.900 |
| 04/10/2024 | 103,64 | 105,74 | 102,20 | 104,78 | +2,48% | 3,42% | 72.500 |
| 03/10/2024 | 101,04 | 105,89 | 100,00 | 102,24 | +2,29% | 5,83% | 85.500 |
| 02/10/2024 | 101,08 | 101,08 | 99,71 | 99,95 | -1,38% | 1,36% | 53.800 |
| 01/10/2024 | 100,10 | 102,15 | 97,78 | 101,35 | +1,26% | 4,37% | 101.800 |
| 30/09/2024 | 97,06 | 100,33 | 97,06 | 100,09 | +2,79% | 3,37% | 74.800 |
| 27/09/2024 | 100,38 | 100,69 | 96,96 | 97,37 | -2,02% | 3,72% | 83.300 |
| 26/09/2024 | 99,73 | 101,01 | 98,40 | 99,38 | +0,61% | 2,62% | 90.500 |
| 25/09/2024 | 99,16 | 99,79 | 97,92 | 98,78 | -0,76% | 1,89% | 71.100 |
| 24/09/2024 | 99,86 | 100,39 | 97,48 | 99,54 | -0,12% | 2,91% | 63.600 |
| 23/09/2024 | 103,29 | 103,29 | 99,27 | 99,66 | -3,05% | 3,89% | 103.600 |
| 20/09/2024 | 104,41 | 105,23 | 102,77 | 102,80 | -2,10% | 2,36% | 384.800 |
| 19/09/2024 | 105,41 | 106,20 | 104,35 | 105,01 | +1,28% | 1,76% | 86.200 |
| 18/09/2024 | 104,02 | 105,91 | 103,15 | 103,68 | -0,56% | 2,65% | 83.800 |
| 17/09/2024 | 105,50 | 106,32 | 104,01 | 104,26 | -0,70% | 2,19% | 91.600 |
| 16/09/2024 | 104,77 | 106,65 | 104,41 | 105,00 | +0,22% | 2,14% | 93.400 |
| 13/09/2024 | 102,62 | 105,40 | 102,62 | 104,77 | +2,62% | 2,71% | 89.900 |
| 12/09/2024 | 103,16 | 104,11 | 101,98 | 102,10 | -0,96% | 2,06% | 54.300 |
| 11/09/2024 | 101,84 | 103,54 | 101,01 | 103,09 | +0,84% | 2,48% | 71.400 |
| 10/09/2024 | 103,10 | 104,28 | 101,73 | 102,23 | -0,54% | 2,47% | 64.900 |